VISION IN THE FUTURE

News

Michael Nash, CCO, presented Re-Vana Therapeutics at the Glaucoma 360 New Horizons Forum

by | Feb 6, 2020 | News | 0 comments

… The late-morning session, titled “New Horizons in Drug Delivery,” will focus exciting innovations in drug delivery systems, with moderators Michael Robinson, MD, vice president and Therapeutic Area head, Allergan; and James C. Tsai, MD, MBA, National Eye Health Education Program (NEHEP) Planning Committee, chairman, NEHEP Glaucoma Subcommittee, National Eye Institute; president, New York Eye and Ear Infirmary of Mount Sinai; chair, Department of Ophthalmology, Icahn School of Medicine at Mount Sinai. Scheduled speakers include Michael H. Goldstein, MD, MBA, Ocular Therapeutix; L. Jay Katz, MD, Glaukos Corp.; Felipe A. Medeiros, MD, PhD, Allergan; Kimberly Cockerham, MD, FACS, 3T Ophthalmics; Casey Dougan, MBA, Kedalion Therapeutics; Michael Nash, Re-Vana Therapeutics; and Murty Vyakarnam, PhD, Zordera Inc.

See the full article at Opthamology Times >>

Do NOT follow this link or you will be banned from the site!